Author(s)

Suishan Qiu, Hui Liu, Huiting Zhong, Leping Li, Lianfang Xue^*

Affiliation(s)

Department of Pharmacy, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China

Corresponding Author

Lianfang Xue

ABSTRACT

This study aimed to determine the bioactive compounds, core genes, and pharmacological mechanisms underlying the effects of Aidi injection (ADI) in non‐small‐cell lung cancer (NSCLC), and to provide a further research directions.The bioactive compounds of ADI were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and the Traditional Chinese Medicines Integrated Database, whiletargets related to these bioactive compounds and NSCLC were obtained from the GEO database. Cytoscape software was used to construct ingredients–protein-targets–pathway networks.Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses and network analysis were performed to investigate potential mechanisms underlying the effects of ADI on NSCLC.This study screened 45 bioactive compounds and 38 major proteins of ADI as potential agents that can act against NSCLC. The results revealed the following potential therapeutic targets of ADI in the treatment of NSCLC: FOS, VEGFA, EGFR, JUN, MMP9, IL2, STAT1, CASP1, NFKBA, and CDK2. The potential mechanisms via which ADI acts against NSCLC are closely related to the inhibition of apoptosis and the activation of signaling pathways.This study has revealed the multicompound, multitarget, and multichannel characteristics of ADI. This provides novel insight into further research investigations of the mechanism of ADI in NSCLC treatment.

KEYWORDS

Non-small-cell lung cancer; Aidi injection; network pharmacology; FOS; VEGFA; EGFR

CITE THIS PAPER

Suishan Qiu, Hui Liu, Huiting Zhong, Leping Li, Lianfang Xue. Treatment of non-small-cell lung cancer with Aidi injection based on network pharmacology. Acta Translational Medicine. 2020, 3(1): 67-76.

REFERENCES

[1] Poston, G.J., Global cancer surgery: The Lancet Oncology review, European Journal of Surgical Oncology. 41 (12) (2015) 1559-1561. 

[2] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A., Jemal, A., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin. 68 (6) (2018) 394-424. 

[3] Ettinger, D.S., Ten years of progress in non-small cell lung cancer, Journal of the National Comprehensive Cancer Network. 10 (3) (2012) 292. 

[4] Yan, M.S., Xiue, S., Wei, L.X., Piao, X.H., The preliminary observation on immunosuppressive effect of norcantharidin in mice, Immunopharmacol Immunotoxicol. 15 (1) (1993) 79-85. 

[5] Wang, G.S., Medical uses of mylabris in ancient China and recent studies, JOURNAL OF ETHNOPHARMACOLOGY. 26 (2) (1989) 147-162. 

[6] Guo, L., Hua, J., Luan, Z., Xue, P., Zhou, S., Wang, X., Qin, N., Effects of the stems and leaves of Astragalus membranaceus on growth performance, immunological parameters, antioxidant status, and intestinal bacteria of quail, ANIMAL SCIENCE JOURNAL. 90 (6) (2019) 747-756. 

[7] Wang, E., Liu, T., Lu, X., Xu, J., Zheng, Q., Zhao, Z., Qu, T., Comparison of aerial parts of Astragalus membranaceus and Astragali Radix based on chemical constituents and pharmacological effects, FOOD AND AGRICULTURAL IMMUNOLOGY. 30 (1) (2019) 1046-1066. 

[8] Mochizuki, M., Yoo, Y.C., Matsuzawa, K., Sato, K., Saiki, I., Tono-oka, S., Samukawa, K., Azuma, I., Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng, BIOLOGICAL & PHARMACEUTICAL BULLETIN. 18 (9) (1995) 1197-1202. 

[9] Liu, H., Zeng, L., Yang, K., Zhang, G., A Network Pharmacology Approach to Explore the Pharmacological Mechanism of Xiaoyao Powder on Anovulatory Infertility, Evid Based Complement Alternat Med. 2016 (2016) 2960372. 

[10] Hopkins, A.L., Network pharmacology: the next paradigm in drug discovery, Nature Chemical Biology. 4 (11) (2008) 682-690. 

[11] Li, B., Xu, X., Wang, X., Yu, H., Li, X., Tao, W., Wang, Y., Yang, L., A systems biology approach to understanding the mechanisms of action of chinese herbs for treatment of cardiovascular disease, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 13 (10) (2012) 13501-13520. 

[12] Zhao, F., Guochun, L., Yang, Y., Shi, L., Xu, L., Yin, L., A network pharmacology approach to determine active ingredients and rationality of herb combinations of Modified-Simiaowan for treatment of gout, JOURNAL OF ETHNOPHARMACOLOGY. 168 (2015) 1-16. 

[13] Boots, A.W., Haenen, G.R., Bast, A., Health effects of quercetin: from antioxidant to nutraceutical, EUROPEAN JOURNAL OF PHARMACOLOGY. 585 (2-3) (2008) 325-337. 

[14] Baby, B., Antony, P., Vijayan, R., Interactions of quercetin with receptor tyrosine kinases associated with human lung carcinoma, NATURAL PRODUCT RESEARCH. 32 (24) (2017) 2928-2931. 

[15] Wang, Q., Chen, Y., Lu, H., Wang, H., Feng, H., Xu, J., Zhang, B., Quercetin radiosensitizes non‐small cell lung cancer cells through the regulation of miR ‐16‐5p/WEE1 axis, IUBMB LIFE. 72 (5) (2020) 1012-1022. 

[16] Harada, D., Takigawa, N., Kiura, K., The Role of STAT3 in Non-Small Cell Lung Cancer, Cancers. 6 (2) (2014) 708-722. 

[17] Nguyen, T.T., Tran, E., Ong, C.K., Lee, S.K., Do, P.T., Huynh, T.T., Nguyen, T.H., Lee, J.J., Tan, Y., Ong, C.S., Huynh, H., Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK, JOURNAL OF CELLULAR PHYSIOLOGY. 197 (1) (2003) 110-121. 

[18] Vaseva, A.V., Moll, U.M., The mitochondrial p53 pathway, Biochim Biophys Acta. 1787 (5) (2009)?M&H ACADEMIC PUBLISHER 76 Treatment of non-small-cell lung cancer with AiDi injection based on network pharmacology 414-420. 

[19] Li, H., Xia, Z., Chen, Y., Yang, F., Feng, W., Cai, H., Mei, Y., Jiang, Y., Xu, K., Feng, D., Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo, CELLULAR PHYSIOLOGY AND BIOCHEMISTRY. 43 (5) (2018) 1829-1840. 

[20] Zhang, W., Zhao, H., Yan, Y., Wang, X., Zhao, Z., Liu, Y., Apoptosis of human lung cancer A549 cells induced by cantharidin and its molecular mechanism, Chinese Journal of Cancer (06) (2005) 330-334. 

[21] Yang, Y., Zhao, Y., Ai, X., Cheng, B., Lu, S., Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis, International Journal of Clinical and Experimental Pathology. 7 (12) (2014) 8453. 

[22] Wang, Z.R., Wang, L., Yin, H.H., Yang, F.J., Gao, Y.Q., Zhang, Z.J., Effect of total flavonoids of hippophae rhamnoides on contractile mechanics and calcium transfer in stretched myocyte, Space Med Med Eng (Beijing). 13 (1) (2000) 6-9. 

[23] Li, Q., Ren, F.Q., Yang, C.L., Zhou, L.M., Liu, Y.Y., Xiao, J., Zhu, L., Wang, Z.G., Anti-proliferation effects of isorhamnetin on lung cancer cells in vitro and in vivo, Asian Pac J Cancer Prev. 16 (7) (2015) 3035-3042. 

[24] Radhakrishna Pillai, G., Srivastava, A.S., Hassanein, T.I., Chauhan, D.P., Carrier, E., Induction of apoptosis in human lung cancer cells by curcumin, CANCER LETTERS. 208 (2) (2004) 163-170. 

[25] Roskoski, R.J., Vascular endothelial growth factor (VEGF) signaling in tumor progression, Crit Rev Oncol Hematol. 62 (3) (2007) 179-213. 

[26] Wei, C., Zhang, J., Li, B., Wang, C., Lv, W., Advances in the study of anti-tumor natural compounds targeting VEGF/VEGFR, Chinese herbal medicine. 48 (23) (2017) 5049-5056. 

[27] Vairaktaris, E., Loukeri, S., Vassiliou, S., Nkenke, E., Spyridonidou, S., Vylliotis, A., Papakosta, V., Lazaris, A., Agrogiannis, G., Yapijakis, C., Perrea, D., Patsouris, E., EGFR and c-Jun exhibit the same pattern of expression and increase gradually during the progress of oral oncogenesis, IN VIVO. 21 (5) (2007) 791-796. 

[28] Talvensaari-Mattila, A., P??kk?, P., Turpeenniemi-Hujanen, T., Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma, BRITISH JOURNAL OF CANCER. 89 (7) (2003) 1270-1275. 

[29] Darlix, A., Lamy, P.J., Lopez-Crapez, E., Braccini, A.L., Firmin, N., Romieu, G., Thezenas, S., Jacot, W., Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastases in metastatic breast cancer patients: predictive biomarkers for brain metastases? INTERNATIONAL JOURNAL OF CANCER. 139 (10) (2016) 2299-2311. 

[30] Hu, Y., Zhu, J., Expression and clinical significance of FOXC2 and MMP-9 in non-small cell lung cancer, Zhejiang Medical Journal. 39 (18) (2017) 1564-1566. 

[31] Zitvogel, L., Kepp, O., Galluzzi, L., Kroemer, G., Inflammasomes in carcinogenesis and anticancer immune responses, NATURE IMMUNOLOGY. 13 (4) (2012) 343-351. 

[32] Chen, Y., Zheng, W., Niu, Z., Wu, Z., Shen, P., Caspase-1 affects the growth mediated by breast cancer and its regulation on myeloid inhibitory cell development, Chinese Journal of Immunology. 29 (11) (2013) 1128-1134. 

[33] Fernandes-Alnemri, T., Wu, J., Yu, J.W., Datta, P., Miller, B., Jankowski, W., Rosenberg, S., Zhang, J., Alnemri, E.S., The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation, CELL DEATH AND DIFFERENTIATION. 14 (9) (2007) 1590-1604.